Stockscreener 앱 받기
2.75
3.00%
0.08
전일 마감가:
$2.67
열려 있는:
$2.68
하루 거래량:
134.18K
Relative Volume:
1.65
시가총액:
$35.32M
수익:
-
순이익/손실:
$-70.20M
주가수익비율:
-0.0614
EPS:
-44.82
순현금흐름:
$-50.66M
1주 성능:
+8.70%
1개월 성능:
+0.00%
6개월 성능:
-36.05%
1년 성능:
+0.00%
1일 변동 폭
$2.63
$2.80
1주일 범위
$2.445
$2.85
52주 변동 폭
$1.70
$19.40
Onkure Therapeutics Inc Stock (OKUR) Company Profile
명칭
Onkure Therapeutics Inc
전화
(720) 307-2892
주소
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
OKUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OKUR
Onkure Therapeutics Inc
|
2.75 | 36.12M | 0 | -70.20M | -50.66M | -44.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-30 | 개시 | Evercore ISI | Outperform |
| 2024-12-05 | 개시 | Leerink Partners | Outperform |
| 2024-10-10 | 개시 | Oppenheimer | Outperform |
| 2023-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-12-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-12-15 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-12-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2023-12-14 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-11-15 | 개시 | William Blair | Outperform |
| 2023-08-28 | 개시 | H.C. Wainwright | Buy |
| 2023-07-03 | 개시 | BofA Securities | Buy |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-01-27 | 개시 | Robert W. Baird | Outperform |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-22 | 개시 | Ladenburg Thalmann | Buy |
| 2021-05-04 | 개시 | Jefferies | Buy |
| 2021-05-04 | 개시 | Piper Sandler | Overweight |
| 2021-05-04 | 개시 | SVB Leerink | Outperform |
모두보기
Onkure Therapeutics Inc 주식(OKUR)의 최신 뉴스
Relative strength of OnKure Therapeutics Inc. in sector analysisMarket Movers & Advanced Swing Trade Entry Plans - newser.com
What data driven models say about OnKure Therapeutics Inc.’s futureMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Using Python tools to backtest OnKure Therapeutics Inc. strategiesJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
OnKure Therapeutics Inc. stock volume spike explainedJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com
Applying Wyckoff theory to OnKure Therapeutics Inc. stockWeekly Investment Recap & Fast Exit and Entry Strategy Plans - newser.com
Can trapped investors hope for a rebound in OnKure Therapeutics Inc.Gap Down & Weekly High Potential Alerts - newser.com
How OnKure Therapeutics Inc. stock trades before earningsWeekly Volume Report & Growth Focused Investment Plans - newser.com
What analysts say about OnKure Therapeutics Inc stockTrading Volume Surges & High Return Wealth Plans - earlytimes.in
What drives OnKure Therapeutics Inc stock priceGrowth vs. Value Investing & You’ve Never Seen Stock Picks Like These - earlytimes.in
Advanced analytics toolkit walkthrough for OnKure Therapeutics Inc.Portfolio Growth Summary & Stepwise Trade Execution Plans - newser.com
LifeSci Capital Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Raises Target Price to $21 - 富途牛牛
OnKure Therapeutics CEO Saccomano sells $230 in stock By Investing.com - Investing.com Australia
OnKure Therapeutics CEO Saccomano sells $230 in stock - Investing.com India
OKUR SEC FilingsOnKure Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Quantitative breakdown of OnKure Therapeutics Inc. recent movePortfolio Return Summary & AI Powered Trade Plan Recommendations - newser.com
Can OnKure Therapeutics Inc. recover in the next quarterJuly 2025 Outlook & Daily Entry Point Alerts - newser.com
Backtesting results for OnKure Therapeutics Inc. trading strategiesEarnings Overview Summary & Stock Portfolio Risk Management - newser.com
Does OnKure Therapeutics Inc have high return on assets2025 Trading Recap & Risk Controlled Stock Pick Alerts - khodrobank.com
Published on: 2025-09-20 08:05:52 - خودرو بانک
Detecting price anomalies in OnKure Therapeutics Inc. with AIPortfolio Gains Report & Weekly Stock Performance Updates - newser.com
Published on: 2025-09-20 05:11:15 - khodrobank.com
Onkure Therapeutics Inc (OKUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):